首页> 外文OA文献 >The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer

【2h】

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer

机译：单中心的真实体验，回顾性研究次生激素剂对激素 - 难治转移前列腺癌患者存活的预后研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sung Han Kim; Done-Eun Lee; Ho Kyung Seo; Jinsoo Chung; Jae Young Joung;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer. [J] . Eymard JC, Priou F, Zannetti A, Annals of oncology: official journal of the European Society for Medical Oncology . 2007,第6期

机译：多西他赛联合雌莫司汀和单药多西他赛在转移性激素难治性前列腺癌患者中的随机II期研究。
2. Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer [J] . J-C Eymard1 F Priou2 A Zannetti3 A Ravaud4 D Lepillé5 P Kerbrat6 P Gomez7 B Paule8 D Genet9 P Hérait10 E Ecstein-Fraïssé11 and F Joly12 Annals of Oncology . 2007,第6期

机译：多西紫杉醇联合雌莫司汀和单药多西紫杉醇在转移性激素难治性前列腺癌患者中的II期随机研究
3. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. [J] . Halabi S, Small EJ, Kantoff PW, Journal of Clinical Oncology . 2003,第7期

机译：预测荷尔蒙顽固性转移性前列腺癌男性生存的预后模型。
4. Identification of Circulating Pluripotent Cancer Stem Cells in the Blood of Prostate Cancer Patients for the Diagnosis of Metastatic Cancer [C] . Anette Claudia Schafer, Yawen Ju, Youngbin Tak, International Molecular Medicine Tri-Conference. . 2016

机译：鉴定前列腺癌患者血液中循环多能癌症干细胞诊断转移性癌症
5. Prognostic Biomarkers for Diffuse Large B Cell Lymphoma Patient Survival after Treatment with Chemotherapy: A Retrospective Analysis of 88 Cases [D] . Bushra, Hamama tul. 2019

机译：弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物：88例回顾性分析
6. Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China [O] . Chang Liu, Ting Li, Zhonghua Tao, 2020

机译：用Palbociclib加内分泌治疗和随后治疗治疗130例激素受体阳性和人表皮生长因子受体2阴性转移性乳腺癌患者的临床结果和疗法：中国的真实单中心回顾性研究
7. Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia [O] . Andika Afriansyah, Agus Rizal AH Hamid, Chaidir A Mochtar, 2018

机译：骨转移前列腺癌患者预后载体的生存分析与发展：印度尼西亚的单中心体验
8. Benzimidazole as Novel Therapy for Hormone-Refractory Metastatic Prostate Cancer [R] . Chung, I. 2011

机译：苯并咪唑作为激素难治性转移性前列腺癌的新型疗法

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅